Acquiring Company
LTS Lohmann Therapie-Systeme AG
Acquired Company
Renaissance Lakewood
Andernach
Lakewood TownshipBiotechnologyPharmaceuticalpharmaceuticalsManufacturingBiotechnologyDescription
LTS Lohmann Therapie-Systeme AG has completed its acquisition of Renaissance Lakewood. The deal, first announced in October 2025, enhances LTS's capabilities in the CDMO sector. Renaissance's facilities and teams will integrate with LTS's existing sites in Germany, the US, and Israel.
Other recent acquisitions in Pharmaceutical and pharmaceuticals
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- SAI Parenterals acquires majority stake in Noumed (December 5, 2025)
- AbbVie to acquire Revolution Medicines soon (January 9, 2026)
- Halozyme acquires Surf Bio for $300 million, $300M (January 28, 2026)
- Atlantic International acquires Circle8 Group (January 23, 2026)
- Cleanova acquires Airflotek and TES-Clean Air Systems (January 8, 2026)
- Pfizer completes $43 billion acquisition of Seagen, $43B (January 4, 2026)
Who to call at LTS Lohmann Therapie-Systeme AG, and when
When LTS Lohmann Therapie-Systeme AG changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day LTS Lohmann Therapie-Systeme AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LTS Lohmann Therapie-Systeme AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LTS Lohmann Therapie-Systeme AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LTS Lohmann Therapie-Systeme AG makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Renaissance Lakewood?
Renaissance Lakewood was acquired by LTS Lohmann Therapie-Systeme AG, based in Andernach. The deal was reported on December 15, 2025. LTS Lohmann Therapie-Systeme AG is a pharmaceutical technology company specializing in drug delivery systems. The company focuses on developing innovative dosage forms and delivery technologies. LTS Lohmann Therapie-Systeme AG is privately held and operates in Biotechnology.
When did LTS Lohmann Therapie-Systeme AG acquire Renaissance Lakewood?
LTS Lohmann Therapie-Systeme AG's acquisition of Renaissance Lakewood was reported on December 15, 2025. LTS Lohmann Therapie-Systeme AG has completed its acquisition of Renaissance Lakewood. The deal, first announced in October 2025, enhances LTS's capabilities in the CDMO sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Renaissance Lakewood do?
Renaissance is a US-based contract development and manufacturing organization (CDMO) for pharmaceutical and biotech. It is privately held, operating in Manufacturing, and is based in Lakewood Township.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.